Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Enteric Diseases
Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.
Technavio’s analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• bioMérieux
• Cepheid
• DiaSorin
Other prominent vendors
• BD
• Biomerica
• Coris BioConcept
• Meridian Bioscience
• Mobidiag
• Quidel
• Quest Diagnostics
• R-Biopharm
• Trinity Biotech
• Thermo Fisher Scientific
Market driver
• Increase in adoption of molecular diagnostic testing
• For a full, detailed list, view our report
Market challenge
• Lack of awareness in underdeveloped countries
• For a full, detailed list, view our report
Market trend
• Shift from singleplex to multiplex testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.
Technavio’s analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• bioMérieux
• Cepheid
• DiaSorin
Other prominent vendors
• BD
• Biomerica
• Coris BioConcept
• Meridian Bioscience
• Mobidiag
• Quidel
• Quest Diagnostics
• R-Biopharm
• Trinity Biotech
• Thermo Fisher Scientific
Market driver
• Increase in adoption of molecular diagnostic testing
• For a full, detailed list, view our report
Market challenge
• Lack of awareness in underdeveloped countries
• For a full, detailed list, view our report
Market trend
• Shift from singleplex to multiplex testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
